Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness
Mounjaro works by targeting two hormones (GLP-1 and GIP), unlike Ozempic, which only targets GLP-1, which may explain its stronger effects
No ocurrieron efectos secundarios severos, y no hubo signos de rebote graso durante las 4 semanas de seguimiento con placebo
Below, well outline some of the most notable benefits observed with both compounds
Challenges include navigating the complex regulatory landscape, managing the high costs of compliance, ensuring the adequacy of quality control measures, and keeping up with changes in regulations
This article aims to explore the topic in a clear, medically informed way to help people understand what may be happening and when it may matter